490 related articles for article (PubMed ID: 19609919)
61. An unusual presentation of Wilson's disease in childhood: nodular fatty infiltration in liver.
Kuloğlu Z; Kansu A; Demirçeken F; Erden E; Fitoz S; Girgin N
Turk J Pediatr; 2008; 50(2):167-70. PubMed ID: 18664082
[TBL] [Abstract][Full Text] [Related]
62. Wilson's disease: a clinico-neuropathological autopsy study.
Meenakshi-Sundaram S; Mahadevan A; Taly AB; Arunodaya GR; Swamy HS; Shankar SK
J Clin Neurosci; 2008 Apr; 15(4):409-17. PubMed ID: 18242093
[TBL] [Abstract][Full Text] [Related]
63. Wilson's disease: A master of disguise.
Hedera P
Parkinsonism Relat Disord; 2019 Feb; 59():140-145. PubMed ID: 30797706
[TBL] [Abstract][Full Text] [Related]
64. Delusional disorder and alcohol abuse in a patient with Wilson's disease.
Spyridi S; Diakogiannis I; Michaelides M; Sokolaki S; Iacovides A; Kaprinis G
Gen Hosp Psychiatry; 2008; 30(6):585-6. PubMed ID: 19061688
[TBL] [Abstract][Full Text] [Related]
65. Constructing "smart" chelators by using an activatable prochelator strategy for the treatment of Wilson's disease.
Wang C; Wang R; Zhao L; Wang S; Liu Y; Zhao J; Dong Y; Liu L; Wei P; Wu ZY; Yi T
Redox Biol; 2024 Apr; 70():103076. PubMed ID: 38340635
[TBL] [Abstract][Full Text] [Related]
66. The treatment of sickle cell anemia and Wilson's disease with zinc.
Brewer GJ; Hill GM
Prog Clin Biol Res; 1983; 127():97-113. PubMed ID: 6889406
[No Abstract] [Full Text] [Related]
67. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.
Nations SP; Boyer PJ; Love LA; Burritt MF; Butz JA; Wolfe GI; Hynan LS; Reisch J; Trivedi JR
Neurology; 2008 Aug; 71(9):639-43. PubMed ID: 18525032
[TBL] [Abstract][Full Text] [Related]
68. Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease.
Benbir G; Gunduz A; Ertan S; Ozkara C
Seizure; 2010 Nov; 19(9):602-4. PubMed ID: 20732822
[TBL] [Abstract][Full Text] [Related]
69. Muscle copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron-activation analysis.
Leu ML; Strickland GT; Beckner WM; Chen TS; Wang CC; Yeh SJ
J Lab Clin Med; 1970 Sep; 76(3):432-8. PubMed ID: 5458332
[No Abstract] [Full Text] [Related]
70. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
71. Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?
Schaumburg H; Herskovitz S
Neurology; 2008 Aug; 71(9):622-3. PubMed ID: 18725588
[No Abstract] [Full Text] [Related]
72. Neurological presentation of Wilson's disease in a patient after liver transplantation.
Litwin T; Gromadzka G; Członkowska A
Mov Disord; 2008 Apr; 23(5):743-6. PubMed ID: 18181205
[TBL] [Abstract][Full Text] [Related]
73. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy.
Goodman BP; Bosch EP; Ross MA; Hoffman-Snyder C; Dodick DD; Smith BE
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):524-7. PubMed ID: 18495738
[TBL] [Abstract][Full Text] [Related]
74. [Multifocal motor neuropathies with conduction block: long-term follow-up of ten patients treated with IVIg].
Cros D; Drake K
Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S46-3S50. PubMed ID: 17075525
[TBL] [Abstract][Full Text] [Related]
75. Neurological Deterioration in Wilson's Disease-Types, Etiology, Course, and Management.
Litwin T; Antos A; Bembenek J; Cz Onkowska A
Discov Med; 2024 Apr; 36(183):646-654. PubMed ID: 38665014
[TBL] [Abstract][Full Text] [Related]
76. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
Deguchi K; Sasaki I; Touge T; Tsukaguchi M; Ikeda K; Shimamura M; Urai Y; Watanabe S; Takeuchi H; Kuriyama S
J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
[No Abstract] [Full Text] [Related]
77. A novel Global Assessment Scale for Wilson's Disease (GAS for WD).
Aggarwal A; Aggarwal N; Nagral A; Jankharia G; Bhatt M
Mov Disord; 2009 Mar; 24(4):509-18. PubMed ID: 19115420
[TBL] [Abstract][Full Text] [Related]
78. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
Foruny JR; Boixeda D; López-Sanroman A; Vázquez-Sequeiros E; Villafruela M; Vázquez-Romero M; Rodríguez-Gandía M; de Argila CM; Camarero C; Milicua JM
Scand J Gastroenterol; 2008; 43(5):597-603. PubMed ID: 18415754
[TBL] [Abstract][Full Text] [Related]
79. Psychosis and Wilson's disease: a case report.
Jukić I; Titlić M; Tonkić A; Dodig G; Rogosić V
Psychiatr Danub; 2006 Jun; 18(1-2):105-7. PubMed ID: 16804509
[TBL] [Abstract][Full Text] [Related]
80. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
